<DOC>
	<DOCNO>NCT01077063</DOCNO>
	<brief_summary>The purpose study ass control prospective setting , safety use Pleurx catheter standard therapeutic paracentesis patient malignant ascites .</brief_summary>
	<brief_title>An Early Safety Efficacy Study Ascites Management : Standard Paracentesis Early Intervention With Pleurx Catheters Patients With Malignant Ascites</brief_title>
	<detailed_description>Study Design : Single institution , open-label , randomize study Study Device : Pleurx Catheter Treatment Plan : Cohort A : 15 patient treated standard therapy ( therapeutic paracentesis +/- diuretic ) Cohort B : 15 patient treated peritoneal Pleurx catheter Duration Participation : Patients follow one year , death , whichever come first . Primary Outcome : Safety Pleurx catheter procedure paracentesis Secondary outcome : Overall complication , quality life , overall survival , symptom control</detailed_description>
	<mesh_term>Ascites</mesh_term>
	<criteria>( Patients receive chemotherapy discretion treat oncologist ) 1 . Patients recurrent malignant ascites 2 . Patients refractory malignant ascites 3 . Proven malignancy 4 . Age &gt; = 18 year old 5 . Eastern Cooperative Oncology Group ( ECOG ) performance scale = &lt; 2 6 . Ability understand willingness sign write informed consent Definitions : Malignant ascites : One follow criterion 1 . Positive ascitic fluid cytology 2 . Histology proven malignancy image study evidence liver metastasis ascites 3 . Malignant Budd Chiari Syndrome associate ascites 4 . Hepatocellular carcinoma ascites 5 . Chylous ascites due lymphoma 6 . Peritoneal carcinomatosis concurrent ascites 7 . Proven abdominal malignancy concurrent ascites Refractory / Recurrent ascites : One follow criterion 1 . Symptomatic ascites recur one paracentesis patient know malignant ascites . 2 . Symptomatic ascites respond clinically least two week diuretic . Use diuretic discretion treat physician . 3 . Intolerance relative contraindication diuretic : ( serum sodium ( Na ) concentration &lt; 125 mmol per liter serum creatinine &gt; 1.5 mg/dl , hyperkalemia ( potassium &gt; 5.2 mEq/L azotemia Bun/Creatinine ratio &gt; 20 ) . 4 . Removal least 5 L precede two month symptom relief Exclusion criterion : 1 . Life expectancy le one month 2 . Coagulopathy ( international normalize ratio [ INR ] &gt; 2 correct fresh frozen plasma ) 3 . Hepatorenal syndrome 4 . Active skin infection abdomen procedure 5 . Inability provide inform consent 6 . Platelet count &lt; 50,000/mcL 7 . Uncontrolled illness include , limited , ongoing active infection require intravenous ( IV ) antibiotic , physician feel would increase risk infection procedure white blood cell ( WBC ) count &gt; 20,000/mcL 8 . Absolute neutrophil count &lt; 1000 / cu mm 9 . Pregnant woman 10 . Multiloculated ascites</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Pleurx catheter</keyword>
	<keyword>malignant ascites</keyword>
</DOC>